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Abstract
Background: Disease management programs (DMP) aim at improving coordination and quality of care and reducing healthcare costs for 
specific chronic diseases. This paper investigates to what extent total healthcare utilization of type 2 diabetes patients is actually related 
to diabetes and its implications for diabetes management programs.
Research design and methods: Healthcare utilization for diabetes patients was analyzed using 2008 self-reported data (n=316) and data 
from electronic medical records (EMR) (n=9023), and divided whether or not care was described in the Dutch type 2 diabetes multidis-
ciplinary healthcare standard.
Results: On average 4.3 different disciplines of healthcare providers were involved in the care for diabetes patients. Ninety-six percent 
contacted a GP-practice and 63% an ophthalmologist, 24% an internist, 32% a physiotherapist and 23% a dietician. Diabetes patients had 
on average 9.3 contacts with GP-practice of which 53% were included in the healthcare standard. Only a limited part of total healthcare 
utilization of diabetes patients was included in the healthcare standard and therefore theoretically included in DMPs.
Conclusion: Organizing the care for diabetics in a DMP might harm the coordination and quality of all healthcare for diabetics. DMPs 
should be integrated in the overall organization of care.
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Introduction
The number of people with chronic diseases, including 
diabetes mellitus, is increasing worldwide due to aging 
and an increasing number of people with overweight 
and physical inactivity. In 2030, the worldwide percent-
age of diabetes patients is estimated to be 4.4%, which 
would be an increase of 60% in comparison with the 
year 2000 [1]. Due to the high burden of chronic dis-
eases for healthcare costs and impact on quality of life, 
management of chronic diseases has been an impor-
tant issue in health policy in many countries [2]. While 
in the US almost all commercial health plans and large 
employers offer some form of disease management 
program (DMP) [3], public purchasers of health ser-
vices have only recently implemented or are planning 
to implement DMPs [4, 5].
According to the Disease Management Association of 
America (DMAA) disease management is defined as 
a system of coordinated healthcare interventions and 
communications for populations with conditions in which 
patients self-care efforts are significant. Disease man-
agement supports the physician or practitioner/patient 
relationship and plan of care, emphasizes prevention of 
exacerbations and complications through the use of evi-
dence-based practice healthcare standards and patient 
empowerment, and evaluates clinical, humanistic, and 
economic outcomes on an ongoing basis with the goal 
of improving overall health [6]. DMPs are expected to 
be the solution for the inadequate coordination of care 
between health services, variation in quality of care and 
increasing costs for chronic illnesses [4].
In the Netherlands, disease management was promoted 
with  the  nationwide  introduction  of  disease  oriented 
funding of chronic care in January 2010 (experimental 
since 2007), also known as bundled payments. Lack 
of collaboration between different healthcare provid-
ers  partly  explained  by  the  fragmented  organization 
of chronic care and funding urged the need for a new 
system of payment and organization for chronically ill 
patients. The basic idea behind disease oriented fund-
ing is that care for specific diseases can be organized 
around the needs of patients by stimulating the mul-
tidisciplinary coordination of care between healthcare 
providers  within  primary  and  between  primary  and 
secondary care. Within disease oriented funding, care 
is provided according to the national multidisciplinary 
evidence-based healthcare standard agreed between 
healthcare providers and patient organizations. Health-
care standards provide information about prevention 
and  treatment  of  a  specific  health  condition  based 
on scientific evidence. To assess the quality of pro-
vided care, feedback and benchmarking reports have 
to be provided. In this way, disease oriented funding 
stimulates the further implementation of disease man-
agement.  Care  has  to  be  organized  by  a  group  of 
healthcare  providers  (who  form  a  legal  entity)  who 
negotiate  a  lumpsum  remuneration  per  patient  with 
insurers. Groups of healthcare providers can provide 
care themselves or subcontract other healthcare pro-
viders [7, 8]. Theoretically, these healthcare providers 
do not have to be the patient’s personal GP, although 
in the Netherlands all inhabitants are obligatory listed 
with a GP-practice. Disease oriented funding was intro-
duced for type 2 diabetes and cardiovascular risk man-
agement in January 2010 and for COPD in July 2010. 
This article focuses on diabetes management.
Since many type 2 diabetes patients also suffer from 
other  chronic  and  acute  illnesses  [9,  10],  only  part 
of the healthcare for these patients will probably be 
included in disease oriented funding and in the disease 
management program. Organizing or financing only a 
part of healthcare for a patient could affect the quality 
and coordination of care on patient level, and thereby 
healthcare outcomes. The objective of this article is to 
examine to what extent total healthcare utilization of 
type 2 diabetes patients is actually related to diabetes 
and therefore theoretically part of a diabetes manage-
ment program in disease oriented funding and to dis-
cuss its implications for DMPs in general.
Methods
Study design
For  the  purpose  of  this  study,  healthcare  utilization 
of known type 2 diabetes patients in the Netherlands 
was  assessed  in  2008  and  compared  to  the  Dutch 
type 2 diabetes multidisciplinary healthcare standard 
to establish which part of this care would be included 
in a DMP for diabetes. This study took place before 
the official introduction of disease oriented funding. In 
the Netherlands, no national database exists that pro-
vides information about all components of healthcare 
utilization of diabetes patients. Therefore, a synthesis 
was performed to estimate the healthcare utilization 
of type 2 diabetes patients using three databases: the 
National Panel of People with Chronic Illness or Dis-
ability (NPCD), the Netherlands Information Network 
of General Practice (LINH) and the National Informa-
tion  Service  for Allied  Healthcare  (LiPZ). The  broad 
healthcare utilization outline was assessed with data 
from  the  NPCG,  which  contains  self-reported  data 
about whether or not diabetes patients consulted vari-
ous healthcare providers. Additional information about 
type and amount of care in primary care and diagno-
ses for which patients were referred to a medical spe-
cialist was derived from LINH and LiPZ. In the Dutch 
healthcare  system,  GPs  act  as  gatekeeper  for  care International Journal of Integrated Care – Volume 11, 14 December  – URN:NBN:NL:UI:10-1-101682 / ijic2011-140 – http://www.ijic.org/
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study, type 1 diabetes patients were excluded on the 
basis of having received a prescription of insulin (ATC-
code A10A), but not any oral anti-diabetic medication   
(ATC-code A10B) [15]. In total, data from 66 GP-prac-
tices and 9023 type 2 diabetes patients were included in 
the analyses. For referrals, data of 48 GP-practices and 
6973 type 2 diabetes patients were included.
The National Information Service for Allied 
Healthcare (LiPZ).
LiPZ  is  a  Dutch  national  representative  network  of 
about 40 physiotherapy practices, 40 practices provid-
ing exercise therapy and 30 dietetics practices [16]. 
Yearly,  14,000,  5000  and  3000  patients  are  treated 
in these practices, respectively. Participants routinely 
record healthcare related data in their EMRs, includ-
ing  the  medical  diagnoses  provided  by  the  referrer 
(ICPC-coded by research assistants). Type 2 diabe-
tes patients and their number of treatment sessions   
cannot directly be selected from the LiPZ-data, since 
only the indication for the treatment (mostly muscu-
loskeletal)  is  recorded  and  not  whether  there  is  an 
underlying comorbid disease. Therefore, we based our 
estimates of the number of treatment sessions (phys-
iotherapist and exercise therapist) or duration of con-
sultations (dietetics) on GPs’ referral diagnoses.
It is important to note that there is no overlap in the 
three  databases  and  only  aggregated  data  from  all 
databases were linked. The databases of NPCD, LINH 
and LiPZ are registered with the Dutch data protection 
authority; all data are collected and handled accord-
ing to the data protection healthcare standards of the 
authority.
Measurements
Broad outline healthcare utilization
The broad outline of healthcare utilization in 2008 was 
assessed in the NPCD panel by means of written struc-
tured  questionnaires  (multiple  choices).  The  overall 
response rate was 81.6%. Healthcare use was mea-
sured using the procedures of the Netherlands Health 
Interview Survey, in order to guarantee valid measure-
ments [17]. Patients indicated whether or not they had 
used healthcare services during the previous year. We 
included the following disciplines/elements: GP, medical 
specialists (outpatient secondary care), allied health-
care, home care, hospital stay and mental healthcare.
Healthcare utilization in primary care
Detailed information about healthcare utilization in pri-
mary care was assessed using data from LINH and 
LiPZ. Healthcare utilization was categorized into con-
tacts with GP-practice, drug prescriptions and health-
care utilization of allied healthcare.
by medical specialists. Diabetes patients need to be 
referred by a GP to visit a medical specialist for the first 
time. The diagnoses for which patients were referred 
to a medical specialist provide an indication about the 
provided care.
National Panel of people with Chronic Illness or 
Disability (NPCD)
The NIVEL research program “National Panel of peo-
ple with Chronic Illness or Disability” is a nationwide 
panel study on the consequences of chronic illness in 
the Netherlands [11, 12]. Panel members are recruited 
from the patient files of general practices. Patients are 
selected according to the following criteria: a diagnosis 
of a non-curable chronic disease by a certified medical 
practitioner, an age ≥15 years, being non-institutional-
ized, being aware of the diagnosis, not being terminally 
ill [life expectancy >6 months according to their gen-
eral practitioner (GP)], being mentally able to partici-
pate, and a sufficient mastery of the Dutch language. 
In April 2009, when the data for the current study were 
collected, the panel consisted of 1819 chronically ill 
patients recruited from 45 GP-practices in 2005, 2006, 
2007 or 2008. For the purpose of this study, self-re-
ported data on healthcare utilization in 2008 were ana-
lyzed of 316 patients diagnosed with type 2 diabetes 
(as index disease or comorbid condition).
The Netherlands Information Network of 
General Practice (LINH)
LINH is a representative sample of GP-practices in the 
Netherlands that provide routinely recorded data from 
their electronic medical records (EMRs). The LINH-da-
tabase holds longitudinal data on morbidity, prescrip-
tions and referrals of approximately 90 GP-practices 
and  350,000  listed  patients  [13].  The  network  is  a 
dynamic pool of practices, with each year some minor 
changes in the number of participating practices. Diag-
noses are coded using the International Classification 
of Primary Care (ICPC) [14].
For our analyses, we used data from practices that (a) 
participated in both 2007 and 2008 and (b) recorded 
year-round data for consultation, prescription and mor-
bidity records in 2008. An additional inclusion criteria 
was set for the referral data of 2008 being recorded 
year round.
Patients were selected if (1) they had consulted their GP 
for type 2 diabetes at least once in 2007 and (2) were 
registered with the practice during the whole year in 2008 
and (3) aged 15 or older. Type 2 diabetes patients were 
selected on the basis of a recorded ICPC-code T90. 
GPs within LINH do generally not record on ICPC-sub   
codes (T90.1 or T90.2), and therefore we could not dis-
tinguish between type 1 and type 2 diabetes patients 
on the basis of ICPC-codes. For the purpose of this This article is published in a peer reviewed section of the International Journal of Integrated Care  4
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Contacts in GP-practice were based on claims-data in 
the EMR in which a distinction was made between con-
sultations (short and long), home visits (short and long) 
and telephone consultations with GP and primary care 
nurse and contacts for ‘diabetes guidance per year’. In 
the Netherlands, GP-practices can claim a fee for so-
called ‘diabetes guidance per year‘. GP-practices can 
claim such guidance 3–4 times a year depending on 
the contract they have with insurers. Within diabetes 
guidance GP-practices have to provide healthcare to 
diabetes  patients  based  on  the  healthcare  standard 
and report back about provided healthcare.
Drug  prescriptions  were  coded  automatically  using 
the ATC classification system. A distinction was made 
between prescriptions for diabetes and those for other 
comorbid conditions, based on ATC codes at the 4 digit 
level.
The healthcare utilization of patients with other allied 
healthcare providers was based on the average num-
ber of treatment sessions (physiotherapist and exer-
cise therapist) or duration of consultations (minutes) 
(dietetics) for the referral diagnoses. For example, if 
a diabetes patient was referred to a physiotherapist 
for  shoulder  complaints  (based  on  LINH),  the  aver-
age number of treatment sessions was based on the 
overall median number of treatment sessions for all 
patients receiving physiotherapists’ care (not just dia-
betes patients) for shoulder complaints (based on LiPZ 
data). The median number of treatment sessions or 
minutes was determined for diagnoses for which more 
than 10 patients visited the allied healthcare provider. 
For referral diagnoses with <10 patients, the overall 
median was taken. In the Netherlands, patients can 
freely  access  physiotherapists  and  since  July  2008 
also exercise therapists.
Healthcare utilization with medical specialists
Healthcare  utilization  with  medical  specialists  was 
obtained  via  NPCD  database.  The  NPCD  does 
not  include  information  about  the  reason  (diagno-
sis)  for  visiting  medical  specialists.  In  LINH  referral 
data are available, which contain all new referrals to 
medical  specialists  including  the  referral  diagnosis   
(ICPC-coded).  In  this  study,  diagnoses  for  which 
patients were referred to a medical specialist will be 
presented in addition to data obtained via NPCD.
Comorbidity
For  all  patients,  the  presence  of  any  other  chronic 
disease was assessed with LINH-data based on the 
recording of any of these diseases in 2007 or 2008. 
The list of chronic diseases is included in Appendix 1 
and is derived from the list used by the Dutch National 
Institute for Public Health and the Environment [18].
Dutch diabetes multidisciplinary healthcare 
standard
In this study, health care as defined in the multidisci-
plinary healthcare standard of the Dutch Diabetes Fed-
eration (NDF: ‘Nederlandse Diabetes Federatie’) was 
compared with the healthcare utilization of type 2 diabe-
tes patients [19]. This healthcare standard includes the 
care as described in the evidence based guideline of the 
Dutch College of GPs. Healthcare utilization was coded 
as  ‘according  to  the  healthcare  standard’,  if  the  pro-
vided care was mentioned in the NDF-healthcare stan-
dard. In case of contacts in general practice, patients 
can visit general practice for more than one complaint 
during  a  visit.  In  such  cases,  a  weighted  number  of 
contacts  ‘according  to  the  healthcare  standard’  was 
calculated (for example when both a cough and diabe-
tes are discussed in a consultation, it is counted as 0.5   
diabetes related consultation). Only healthcare utilization 
that could be captured with ICPC-codes was taken into 
account. Box 1 shows healthcare utilization for known 
type 2 diabetes patients based on the NDF-healthcare 
standard with the corresponding ICPC-codes.
Statistical analyses
The analysis of the healthcare utilization of type 2 dia-
betes  patients  was  primarily  descriptive.  Healthcare 
utilization was presented in a diagram which includes 
all services, and for certain parts a specific descrip-
tion of the healthcare utilization. Within this diagram, 
we highlighted the healthcare utilization that was part 
of the healthcare standard for diabetes to show which 
part of the total healthcare utilization is diabetes related 
and would therefore be included in a DMP for diabetes. 
Last, the number of other chronic diseases and most 
common combinations of diseases in diabetes patients 
was calculated based on morbidity data in LINH.
Results
Figure 1 shows an estimate of the total healthcare 
utilization  of  the  type  2  diabetes  patients  in  2008 
based on data from NPCD, LINH and LiPZ. On top of 
the figure for all components of healthcare (GP-care, 
outpatient secondary care, allied healthcare) the per-
centage of diabetes type 2 patients having used these 
care components in 2008 is shown. For example, all 
diabetes type 2 received drug prescriptions in 2008. 
Below, the components are, if possible, further divided. 
For  example,  outpatient  secondary  care  is  further 
divided into the different medical specialists with the 
percentage of diabetes type 2 patients visiting these 
specialists. These percentages represent the health 
care use of the total diabetes type 2 population, so 
not only diabetes related care. Under this subdivision International Journal of Integrated Care – Volume 11, 14 December  – URN:NBN:NL:UI:10-1-101682 / ijic2011-140 – http://www.ijic.org/
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Box 1. Health care utilization for known type 2 diabetes patients based on Dutch Diabetes Federation type 2 diabetes healthcare standard
Check-ups by GP and primary care nurse
  3-  montly check-up: wellbeing, hypo- or hyperglycemia, nutritional problems or exercise advice and medication, body weight, fasting blood 
glucose levels, blood pressure (if patient uses antihypertensive drugs), foot examination (if patient had ulcus, acquired deformity of 
limb or serious neuropathy foot)
  Yea  rly check-up: possible visual problems, cardiovascular diseases, neuropathy or sexual problems, lifestyle aspects as smoking status, 
exercise and alcohol use, blood pressure, body weight, foot examination, inspection insuline injection sites (if patients uses insuline), 
eye fundus examination. Laboratory measures: fasting blood glucose, HbA1c, creatinine levels, potassium levels (if patient uses 
diuretic or RAS inhibitor), creatinine clearance, albumin creatinine-ratio or albumin urine levels (if patients has a life expectancy of 
minimal 10 years), fasting lipids spectrum
Medication
  Diabetes: oral blood glucose lowering drugs, insulin
    Ris  k factor cardiovascular diseases: lipid modifying agents (recommended for almost all type 2 diabetes patients), diuretics, ACE 
inhibitors, angiotensin-ii-antagonists, beta blocking agents, calcium channel blockers, antithrombotic agents
    Superficial foot ulcer: oral antibiotic
Consultation other healthcare providers
    Inte  rnist (including nephrologist): adjustment insulin (when knowledge not available in GP-practice), insufficient correction postprandial 
blood glucose levels with two-times daily insulin, diabetes ulcer, low creatinine clearance, serious hyperglycemia or hyperglycemic 
coma, pregnant women or women with pregnancy wish
  Dietician: for extensive nutrition advice
    Ophthalmologist: retinaphotography (if not available in GP-practice), assessment of retinaphotography (if expertise not available in 
GP-practice), deviations eye fundus
  Podotherapist: callous and/or pressure sites without signs of peripheral vascular disease
  Surgeon: diabetes ulcer
  Orthopedic: diabetes ulcer
  Dermatologist: diabetes ulcer
  Based on the described healthcare utilization the following ICPC-codes were coded as ‘according to the healthcare standard’ see Table 2.
more detailed information is shown (if available). For 
example for GPs, the number of diabetes related and 
diabetes unrelated contacts is provided and for medi-
cal specialists the referral diagnoses are shown. The 
percentages of patients presented here are again a 
percentage of the total diabetes type 2 population. 
In this way the average utilization of diabetes type 2 
patients can be calculated through adding up all dif-
ferent components of healthcare utilization.
Total healthcare utilization
Most  diabetes  patients  (96%)  used  services  from   
GP-practice, mostly provided by the GPs themselves. 
The  total  contact  rate  was  4.9  for  diabetes  related 
contacts and 4.3 contacts per year for non-diabetes 
related symptoms and diseases. Diabetes patients had 
on average 9.3 contacts with a GP-practice of which 
53% specifically for diabetes. Most diabetes patients 
(93%) used also other outpatient secondary care ser-
vices. Almost three quarters of the patients had con-
sulted  a  specialized  nurse.  Frequently  encountered 
medical  specialists  included  ophthalmologists  (63%), 
internists  (24%)  and  surgeons  (15%).  Furthermore, 
18% of the diabetes patients were hospitalized in 2008. 
Allied healthcare providers, including physiotherapists 
(32%) and dieticians (23%), were contacted by many 
diabetes patients. All diabetes patients received drug 
prescriptions  in  2008  for—on  average—7.6  different 
drugs. The most frequently prescribed drugs included 
blood glucose lowering drugs excluding insulin (73%) 
and  medication  for  cardiovascular  diseases  or  risk 
management including lipid modifying agents (64%), 
and antithrombotic agents (37%). The care for diabe-
tes patients was on average provided by 4.3 (SD: 2.0) 
healthcare providers of different disciplines, with 20% 
of the patients receiving care from six or more health-
care providers. This includes healthcare providers both 
in primary healthcare and in secondary care, excluding 
specialized nurses.
Diabetes healthcare standards
Only a part of the healthcare utilization of type 2 dia-
betes patient is included in the Dutch healthcare stan-
dard (highlighted in Figure 1). This included in total 
36% of the contacts of GPs and 95% of the care pro-
vided by primary care nurses. Furthermore, internists’ 
care  for  diabetes,  part  of  surgeons’,  cardiologists’,   
neurologists’  and  ophthalmologists’  care,  dieticians’ 
care, podiatrists’ care and most of the 10 most fre-
quently prescribed drugs was according to the stan-
dard. An important reason for the part of healthcare 
utilization  not  included  in  the  healthcare  standards 
is the high rate of comorbidity in diabetics: 60% of 
diabetes patients had another chronic disease: 31% 
had one, 17% two and 12% had three or more other 
chronic diseases. The most common comorbid condi-
tions were coronary heart diseases (15.%), followed 
by dermatitis (14%) and osteoarthritis (9%) (Table 1). This article is published in a peer reviewed section of the International Journal of Integrated Care  6
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In Online Appendix Table A1 a full description of all 
other chronic diseases in type 2 diabetes patients is 
shown.
Discussion
The aim of this paper was to show to what extent the 
total healthcare utilization of type 2 diabetes patients is 
disease specific and what part is not, in order to draw 
inferences for DMPs. Diabetes patients received care 
from on average 4.3 different disciplines of healthcare 
providers in 2008. Coordination of care is, therefore, of 
great importance. DMPs aim to promote the coordina-
tion of care and stimulate multidisciplinary cooperation. 
However, only a part of the healthcare utilization of dia-
betes patients is described in the healthcare standard 
and would therefore theoretically be included in a DMP 
for diabetes, as earlier shown by Hodgson and Cohen 
(1999) who estimated that the expenditure for diabetes 
care was only 40% of the total health care expenditure 
Table 1. Top-10 of other chronic diseases in type 2 diabetes patients 
based on LINH (n=9023), 2008
Chronic disease Percentage of type 2 
diabetes patients
Coronary heart disease 15.3%
Dermatitis 13.5%
Osteoarthritis   8.7%
Chronic obstructive pulmonary disease 
(COPD)
  8.6%
Chronic neck or back syndrome   7.7%
Asthma   6.9%
Visual disorder   6.9%
Heart failure   6.7%
Cancer   6.7%
Transient cerebral ischaemia/
cerebrovascular accident
  6.3%
Table 2. ICPC-codes included as ‘diabetes-related’ according to the 
Dutch Diabetes Federation type 2 diabetes healthcare standard
F05: Visual disturbance other
F83: Retinopathy
F94: Blindness
K74: Angina pectoris
K75: Acute myocardial infarction
K76:   Ischemic heart disease w/o 
angina
K86: Hypertension uncomplicated
K87: Hypertension complicated
K89: Transient cerebral ischemic
K90: Stroke/cerebrovascular disease,
K99.06:   Peripheral diabetic 
angiopathy
L98: Acquired deformity limb
N94: Peripheral neuritis/neuropathy
P07: Sexual desire reduced
P08: Sexual fulfillment reduced
P17: Tobacco abuse
S06: Rash localized
S11:   Other local 
infection skin
T02: Excessive appetite
T03: Loss of appetite
T05:   Feeding problem 
of adult
T07: Weight gain
T08: Weight loss
T82: Obesity
T83: Overweight
T90: Diabetes mellitus
T93: Lipid disorder
X24:   Fear of sexual 
dysfunction female
Y07: Impotence NOS
Y24:   Fear of dysfunction 
male
[20]. Diabetes related healthcare included 53% of con-
tacts of GPs and primary care nurses, part of care of 
medical specialists, dieticians’ care, podiatrists’ care 
and most of the 10 most frequently prescribed drugs. 
This can partly be explained by the high rate of comor-
bidity in diabetes patients (60% had one or more other 
chronic diseases), as shown by earlier research that 
showed that both diabetes related and diabetes-unre-
lated comorbidity increases the use of medical care in 
diabetes patients [21]. A recent review also showed a 
positive  association  between  multiple  chronic  condi-
tions and health care utilization and expenditure [22]. 
But the fact remains that a large part of the health-
care utilization of type 2 diabetes patients would not be 
included in diabetes DMPs if these DMPs would focus 
exclusively on diabetes.
What does this mean for the coordination of care at 
patient level? In the case of the Netherlands, GPs 
function  as  gatekeeper  and  patients  are  registered 
with a GP-practice [23]. The coordination on patient 
level is the task of GPs. They should have an overview 
of all patients’ health problems and healthcare utiliza-
tion. This means that healthcare is patient-oriented 
and  GPs  provide  healthcare  services  being  aware 
of all health conditions, which is especially important 
in  patients  with  multiple  chronic  diseases  as  most 
diabetes patients [24]. The fact that only half of the 
healthcare of diabetes patients would be included in 
a DMP and therefore in disease oriented funding may 
hamper the coordination and continuity of care. Care 
within disease oriented funding does not have to be 
provided by the patient’s own GP, and therefore not 
all patients’ health problems and healthcare utilization 
could be available for and coordinated by one health-
care provider. In the Netherlands, disease oriented 
funding is usually contracted by groups of GPs in a 
specific area which not necessarily include all GPs 
in the region [25]. To facilitate disease management 
within disease oriented funding, these groups have 
their own specifically designed recording system. The 
risk of this separate recording is that health problems 
and utilization provided within disease oriented fund-
ing are not recorded or copied to the general EMR of 
the patient. Also, diabetes is one of the first diseases 
with disease oriented funding in the Netherlands. Dis-
ease oriented funding is also introduced for COPD 
and planned to be introduced for heart failure in the 
near future. Since 9% of the type 2 diabetes patients 
also  suffer  from  COPD  and  7%  from  heart  failure, 
coordination and continuity of care between different 
DMPs will be a challenge. The introduction of DMP 
with  disease  oriented  funding  will  therefore  prob-
ably improve the quality and coordination on disease 
level, but could potentially violate the coordination on 
patient level.This article is published in a peer reviewed section of the International Journal of Integrated Care  8
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The  Dutch  situation  shows  that  notwithstanding  the 
potential of DMP shown in some studies of DMPs [25], 
implementing DMP in countries with a strong GP sys-
tem  [22]  could  threaten  the  coordination  on  patient 
level which is so important in these countries. In coun-
tries with strong GP-care, policy makers must carefully 
design DMP, in order to prevent threats to the coordina-
tion of care on patient level. An example of a strong GP 
system which has integrated chronic care in the organi-
zation of primary healthcare as a whole is the UK. The 
UK has implemented a ‘Quality and Outcomes Frame-
work’ (QOF) in primary care, which involves additional 
remuneration if GPs meet certain quality requirements 
for chronically ill patient groups [27]. These include indi-
cators for quality of recording, process and outcome. In 
this case no threats are being made to the coordina-
tion of care on patient level. The coordination between 
primary and secondary care is in the UK, however, still 
a problem. Within countries with a less strong GP-care 
tradition like the US, DMPs might improve current extent 
of coordination on both disease and patient level, since 
the coordination and continuity of health care is usually 
not yet the responsibility of a single health care provider. 
In Germany, with a relatively weak primary care sys-
tem, health insurers receive higher payments (separate 
group in risk adjustment system) for certain chronically 
ill patients included in certified DMPs, with the incentive 
for health insurers to develop DMPs [28, 29]. In this sys-
tem more flexibility exists to develop DMPs for patients 
with multiple chronic diseases, although currently DMPs 
in Germany focus on single chronic diseases. This sys-
tem with additional payments for patients with chronic 
conditions in a DMP might also be an option for coun-
tries with a strong health care system, since it does not 
intent to separate the healthcare for patients.
Perhaps  even  more  importantly  DMPs  should  not 
focus  on  a  single  disease,  but  all  more  common 
chronic conditions, since non-communicable diseases 
as coronary heart diseases, COPD and asthma are 
common in diabetes patients. By designing DMPs for 
the most common combinations of chronic conditions 
of patients, coordination of care on patient level is a 
better safeguarded.
Limitations
This  paper  presents  an  overview  of  the  healthcare 
utilization and comorbidity patterns of type 2 diabe-
tes  patients  based  on  three  different  databases. An 
important limitation of this study was the construction 
of the healthcare utilization based on aggregated data 
from different databases. The current databases could 
not be linked at patient level, and consequently some 
outcomes  were  based  on  only  316  type  2  diabetes 
patients, whereas others have been based on more 
than 9000 patients. In addition, healthcare utilization 
as presented in this study does not reflect ideal level 
of healthcare, and could be different from healthcare 
utilization when more healthcare is delivered accord-
ing to disease management. But, it does give a good 
insight into the potential part of care not included in 
national DMPs. Last, in LiPZ no information was avail-
able about diabetes as comorbidity, and therefore allied 
health care use could only be estimated indirectly.
Conclusion
The care for type 2 diabetes patients involves several 
healthcare providers and good coordination of care is 
of great importance. Not all healthcare used by diabet-
ics was diabetes related, and therefore not described in 
the healthcare standard, and theoretically not included 
in DMPs. In countries with strong GP-care this could 
potentially  worsen  the  coordination  and  continuity  of 
care and thereby the quality of care. To improve overall 
healthcare for type 2 diabetes patients focus should also 
be placed on the coordination between diabetes related 
and non-related care in designing DMPs. DMPs should 
be integrated in the overall organization of care.
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Appendix 1
Table A1. List of chronic diseases with ICPC-code and percentage of type 2 diabetes patients with the chronic disease 
Chronic disease ICPC-code Percentage of type 2 
diabetes patients
Tuberculosis A70   0.0%
HIV-infection/AIDS B90   0.0%
Cancer A79, B72, B73, D74, D75, D77, L71, N74, R84, R85, S77, 
T71, U75, U76, U77, W72, X75, X76, X77, Y77, Y78
  6.7%
Peptic or duodenal ulcer D85, D86   0.9%
Chronic enteritis/ulcerative colitis D94   0.5%
Visual disorder F83, F84, F92, F93, F94   6.9%
Hearing disorder H84, H85   1.5%
Congenital anomaly cardiovascular K73   0.0%
Coronary heart diseases K74, K75, K76 15.3%
Heart failure K77   6.7%
Transient cerebral ischaemia/ 
  cerebrovascular accident
K89, K90   6.3%
Chronic neck or back syndrome L83, L84, L85, L86   7.7%
Rheumatoid arthritis L88   1.8%
Osteoarthritis L89, L90, L91   8.7%
Osteoporosis L95   3.2%
Congenital anomaly neurological N85   0.0%
Multiple sclerosis N86   0.1%
Parkinson N87   0.6%
Epilepsy N88   0.8%
Chronic alcohol abuse P15   0.9%
Dementia P70   1.6%
Schizophrenia P72   0.3%
Anxiety disorder, other neurosis P74, P79   2.0%
Depression P76   5.8%
Mental retardation P85   0.1%
Chronic obstructive pulmonary 
diseases (COPD)
R91, R95   8.6%
Asthma R96   6.9%
Dermatitis S87, S88 13.5%
Anorexia T06   0.0%
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